Entrar/Registro  
HOME SPANISH
 
Revista de la Asociación Dental Mexicana
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista de la Asociación Dental Mexicana >Year 2002, Issue 3


Calleja QEA, Gómez CJF, Grcía HAL
Antibiotics employment in odontogenic infections in pregnant patients
Rev ADM 2002; 59 (3)

Language: Español
References: 22
Page: 94-99
PDF: 92.12 Kb.


Full text




ABSTRACT

Dental treatment in pregnant patients in Mexico is frequent. Dentist must be able to choose a harmful antibiotic for the mother and fetus. The fetus may be the target of teratogenetic action in any time during the intrauterine development, the most sensitive period is the first trimester of pregnancy, any elective treatment must be delayed. The risk of bacteremia or septicemia could be at any time of the pregnancy and the results could be more toxic to the fetus than the effect of an antibiotic. Amoxicillin is the first choice antibiotic for odontogenic infections during pregnancy. It is better absorbed from the gastrointestinal tract and provides higher and more sustained serum levels and post-antibiotic effect. If patient is allergic to penicillins, clindamycin is one recommended alternative. The relationship between periodontal infections and pre-term low birth weight make us to consider treatment of pregnant patient to avoid odontogenic infections.


Key words: Pregnancy, antibiotics, odontogenic infections.


REFERENCIAS

  1. INEGI Dirección General de Estadística, Dirección de Estadísticas Demográficas y Sociales, 1997.

  2. Mariotti A. Sex steroid hormones and cell dynamics in the periodontium. Crit Rev Oral Biol Med 1994; 5: 27-53.

  3. Tsai CC, Chen KS. A study on sex hormones in gingival crevicular fluid and black pigmented bacteria in subgingival plaque of pregnant women. Gaoxiong Yi Xue Ke Xue Za Zhi 1995; 11: 265.73.

  4. Santibáñez MP, Herrera E, Fernández MA, Pacheco AI. Frecuencia de caries y enfermedad parodontal en embarazadas. Rev Fac Med UNAM 1998; 41: 141-144.

  5. Vázquez LR, Ovalle CWJ. Lesiones buco-patológicas más frecuentes en la mujer embarazada. Revista ADM 1994; LI: 21-28.

  6. Shrout KM, Robert WC, Billy JP, Bruce PM. Treating the pregnant dental patient: four basic rules addressed JADA 1992; 123: 75-80.

  7. Williams CECS, Davenport ES, Sterne JAC, Sivapathasundaram V, Fearne JM, Curtis MA. Mechanisms of risk in preterm low-birthweight infants. Periodontology 2000, 2000; 23: 142-150.

  8. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000; 13: 547-58.

  9. Gideon K. Aspectos especiales de la farmacología perinatal y pediátrica. En: Katzung BG. Farmacología básica y clínica 1999, 7ª edición. Ed. Manual Moderno.

  10. Hersh EV. Adverse drug interactions in dental practice: interactions involving antibiotics. JADA 1999; 130: 236-251.

  11. Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg, Oral Med, Oral Pathol, Oral Radiol, Endod 2000; 90: 600-608.

  12. Chaim W, Mazor M. Intramniotic infection with fusobacteria. Arch Gynecol Obstet 1992; 251: 1-7.

  13. Baker KA, Fotos PG. The management of odontogenic infections. A rationale for appropriate chemotherapy. Dental Clinics of North America 1994; 38: 689-706.

  14. Brigs GG, Freeman RK, Yasse SJ. A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation, 4 Edition. Mirilan, Williams and Wilkins Galt, 1994.

  15. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study. Arch Gynecol Obstet 2000; 263: 178-81 PMID: 10834326.

  16. Berkovitch M, Segal-Socher I, Greenberg R, Bulkowshtein M, Arnon J, Merlob P, Or-Noy A. First trimester exposure to cefuroxime: a prospective cohort study. Br J Clin Pharmacol 2000; 50: 161-5.

  17. Sasaki J, Morishima T, Sakamoto H. Clinical evaluation of clarithromycin in treatment of acute dental infection. Jpn J Antibiot 1989; 42: 983-1013.

  18. Drinkard CR, Shatin D, Clouse J. Postmarketing surveillance of medications and pregnancy outcomes: clatrithromycin and birth malformations. Pharmacoepidemiol Drug Saf 2000: 549-556.

  19. Sandor GK, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998; 64: 508-14.

  20. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993; 82: 348-352.

  21. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172: 525-529.

  22. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105: 322-327.






>Journals >Revista de la Asociación Dental Mexicana >Year 2002, Issue 3
 

· Journal Index 
· Links 






       
Copyright 2019